Type 2 Diabetes (T2D)Symptoms, Doctors, Treatments, Advances & More
Type 2 Diabetes (T2D) Overview
Learn About Type 2 Diabetes (T2D)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Park Nicollet Clinic-St Louis Park
Richard Bergenstal is an Endocrinologist practicing medicine in Minneapolis, Minnesota. Dr. Bergenstal is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young.
Scripps Clinic John R. Anderson V Medical Pavilion
Athena Philis is an Endocrinologist practicing medicine in La Jolla, California. Dr. Philis is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).
North County Endocrine Medical Group
Timothy Bailey is an Endocrinologist practicing medicine in Escondido, California. Dr. Bailey is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.
Summary: The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report better awareness of their foot placement on the ground. Researchers will compare Walkasins users to a control group of parti...
Design: This is an 8-week, randomized, open-label, parallel-group, superiority pilot study with a 1:1:1 allocation ratio. A total of 45 participants will be enrolled and assigned to one of three arms: 1. Intervention Arm 1: SnapD application + Real-time CGM + Diabetes Self-Management Education and Support (DSMES) 2. Intervention Arm 2: SnapD application standalone + DSMES 3. Control Arm: DSMES alone Inclu...